respiratori
tract
infect
rti
involv
varieti
virus
bacteria
conveni
detect
multiplex
nucleic
acid
amplif
test
nat
compar
novel
luminexbas
nxtagrespiratori
pathogen
panel
nxtagrpp
routin
multiplexligationnat
base
respiratori
specimen
includ
nasopharyng
swab
bronchoalveolar
lavag
throat
swab
tracheal
secret
sputum
children
adult
extract
use
corbett
qiagen
analyz
parallel
routin
nxtagrpp
concord
result
obtain
case
consist
concord
posit
concord
neg
result
discord
consist
posit
neg
neg
posit
result
nxtagrpp
versu
respect
coinfect
observ
nxtagrpp
addit
viral
pathogen
identifi
nxtagrpp
involv
dual
infect
rhinoviru
rsv
discord
sampl
mainli
due
low
genom
signal
c
less
retest
qnat
suggest
higher
sensit
nxtagrpp
also
detect
multipl
infect
handson
time
extract
sampl
hr
nxtagrpp
hr
respect
median
turnaround
time
hr
rang
hr
nxtagrpp
hr
rang
hr
nxtagrpp
show
compar
detect
rate
respiratori
pathogen
handson
turnaround
time
consider
shorter
clinic
signific
detect
multipl
virus
need
clinic
evalu
respiratori
tract
infect
rti
involv
wide
varieti
differ
etiolog
agent
among
virus
bacteria
increas
avail
specif
sensit
diagnost
assay
use
nucleic
acid
amplif
test
nat
becom
clear
etiolog
diagnosi
base
sign
symptom
unreli
sinc
clinic
present
differ
caus
agent
often
similar
especi
immunocompromis
patient
ison
hirsch
et
al
note
limit
also
appli
period
higher
pretest
probabl
epidem
report
previous
grondahl
et
al
therefor
rapid
correct
identif
rti
agent
import
infect
control
treatment
strategi
although
nearpati
test
avail
particularli
import
treat
influenza
khanna
et
al
beckmann
hirsch
neg
result
satisfactori
especi
immunocompromis
patient
ison
hirsch
et
al
challeng
conveni
tackl
nat
multipl
pathogen
parallel
multiplex
nat
platform
abl
detect
differ
virus
bacteria
singl
assay
often
technic
demand
prepar
process
readout
increas
handsontim
hot
affect
turnaroundtim
tat
caliendo
routin
introduc
respifind
platform
reijan
et
al
identifi
respiratori
pathogen
symptomat
children
adult
nickel
et
al
sidler
et
al
detect
differ
pathogen
use
multiplex
ligationdepend
probe
amplif
mlpa
coupl
capillari
electrophoresi
howev
procedur
demand
consider
hot
current
tat
hr
limit
clinic
util
especi
immunocompromis
critic
ill
patient
therefor
compar
nxtagrespiratori
pathogen
panel
nxtagrpp
combin
multiplex
rtpcr
bead
hybrid
detect
identif
virus
bacteria
associ
viruslik
rti
total
respiratori
specimen
obtain
patient
total
nucleic
acid
extract
assay
ml
respiratori
specimen
use
corbett
qiagen
hilden
germani
tat
hr
perform
describ
manufactur
hot
depend
number
sampl
process
hr
sampl
analysi
capillari
electrophoresi
yield
tat
hr
beckmann
hirsch
nxtagrpp
closedtub
assay
consist
multiplex
revers
transcript
pcr
hybrid
singl
step
format
requir
hot
less
min
sampl
tat
hr
nxtagrpp
result
obtain
mean
fluoresc
intens
mfi
measur
luminex
magpix
instrument
research
use
version
tda
softwar
mfi
valu
threshold
particular
pathogen
indic
detect
target
posit
result
limit
detect
target
depend
indic
manufactur
serv
primari
refer
test
discord
result
led
retest
use
local
inhous
quantit
pcr
qnat
three
specimen
sent
extern
refer
laboratori
dr
c
tapparellvu
l
kaiser
univers
hospit
geneva
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
calcul
nxtagrpp
comparison
use
tabl
agreement
two
method
assess
kappa
valu
test
kappa
valu
repres
fair
agreement
moder
agreement
indic
substanti
almost
perfect
agreement
respect
evalu
statist
signific
differ
nxtagrpp
twotail
mcnemar
test
use
concord
result
obtain
sampl
consist
concordantposit
concordantneg
discord
result
assay
seen
consist
nxtagrpp
neg
pair
nxtagrpp
posit
pair
singl
infect
found
sampl
frequent
detect
rhinoenteroviru
influenza
b
clinic
specimen
consist
nasopharyng
swab
obtain
children
bronchoalveolar
lavag
bal
fig
obtain
children
pathogenspecif
detect
rate
two
multiplex
assay
shown
figur
among
retrospect
analyz
specimen
pathogen
found
singl
dual
infect
result
sensit
specif
nxtagrpp
compar
among
prospect
analyz
specimen
pathogen
detect
indic
sensit
specif
nxtagrpp
compar
detect
rate
three
frequent
found
individu
target
retrospect
cohort
prospect
cohort
statist
signific
differ
assay
except
rhinoenteroviru
detect
show
higher
posit
rate
retrospect
cohort
tabl
iib
coinfect
observ
nxtagrpp
addit
viral
pathogen
identifi
nxtagrpp
involv
dual
infect
rhinoenteroviru
respiratori
syncyti
viru
multipl
infect
four
sampl
contain
tripl
infect
detect
assay
tabl
case
coinfect
sole
detect
nxtagrpp
case
nxtagrpp
case
discord
sampl
mainli
due
low
pathogen
level
retest
qnat
due
higher
sensit
nxtagrpp
assay
result
also
detect
multipl
infect
use
refer
nxtagrpp
overal
higher
posit
rate
sensit
specif
ppv
npv
kappa
valu
tabl
iia
mycoplasma
pneumonia
detect
case
time
period
rti
involv
varieti
virus
bacteria
conveni
detect
multiplex
nat
studi
present
direct
comparison
current
routin
assay
novel
nxtagrpp
rti
specimen
symptomat
adult
children
overal
concord
assay
result
high
sampl
overal
posit
rate
lead
pathogen
rhinoenteroviru
parainfluenzaviru
influenzaviru
respiratori
syncyti
viru
fig
pathogenspecif
result
highli
concord
respiratori
syncyti
viru
b
human
metapneumoviru
influenza
influenza
influenza
b
human
coronavirus
legionella
pneumophila
kvalu
tabl
iia
wherea
adenoviru
rhinoenteroviru
human
bocaviru
human
coronavirus
slightli
lower
kvalu
strike
differ
observ
human
coronavirus
kvalu
pneumonia
kvalu
still
interpret
almost
perfect
agreement
though
posit
rate
low
draw
conclus
discord
result
verifi
qnat
associ
high
cycl
threshold
c
valu
indic
low
genom
load
data
shown
detect
addit
rhino
enteroviru
singl
import
caus
discord
seem
result
higher
sensit
nxtagrpp
compar
clearli
role
rhinoenteroviru
detect
particularli
dual
infect
requir
addit
studi
point
recent
milano
et
al
piralla
et
al
nxtagrpp
suffer
occasion
invalid
result
due
low
bead
count
disappear
handson
experi
technician
failur
invalid
intern
control
technic
issu
seen
less
requir
repeat
test
specimen
type
consist
mostli
nasopharyng
swab
bal
submit
one
fourth
case
requir
invas
procedur
typic
appli
patient
signific
clinic
problem
note
differ
seen
rate
discord
result
bal
versu
npa
limit
current
studi
low
number
detect
pathogen
pneumonia
rare
detect
two
case
time
period
suggest
virus
main
caus
rti
pediatr
adult
patient
ruuskanen
et
al
l
pneumophila
frequent
one
posit
specimen
wherea
posit
result
chlamydophila
pneumonia
particular
attent
paid
perform
assay
qualiti
assur
program
view
consider
number
differ
pathogen
cover
qualiti
assur
program
becom
real
financi
organiz
challeng
diagnost
laboratori
given
goal
yearli
particip
given
overal
high
concord
novel
nxtagrpp
observ
studi
argument
eas
handl
hot
tat
ce
mark
cost
becom
critic
issu
ce
mark
obtain
meantim
cost
address
present
howev
eas
handl
hot
clearli
favor
novel
nxtagrpp
larg
due
lyophil
master
mix
seal
readytous
microtit
plate
bead
technolog
includ
pcr
hybrid
one
step
reduc
hot
less
min
even
larg
number
parallel
sampl
scalabl
depend
season
demand
test
tat
rang
hr
median
hr
contrast
sampl
numberdepend
hot
hr
sampl
respect
includ
pcr
hybrid
ligat
denatur
analysi
capillari
electrophoresi
yield
tat
rang
hr
median
hr
taken
togeth
nxtagrpp
provid
highli
concord
result
sensit
new
assay
excel
even
seem
superior
sensit
pathogen
easeofhandl
hot
tat
favor
nxtagrpp
remain
gener
challeng
interpret
multipli
posit
nat
result
clinic
even
symptomat
children
adult
requir
addit
clinic
laboratori
qualifi
requir
thank
sylvi
goepfert
elisabeth
hohmann
sibyl
stauffer
excel
technic
assist
technician
divis
infect
diagnost
laboratori
molecular
diagnost
laboratori
viru
isol
gener
support
project
also
wish
thank
prof
l
kaiser
dr
c
tapparel
univers
hospit
geneva
hug
independ
confirmatori
analysi
three
sampl
professor
ulrich
heining
ur
frey
univers
children
hospit
basel
ukbb
excel
collabor
regard
pediatr
infect
diagnost
nxtagrpp
reagent
ppv
posit
predicitv
valu
npv
neg
predict
valu
k
kappa
interobserv
agreement
number
percentag
total
posit
neg
detect
nxtagrpp
retrospect
prospect
sampl
number
percentag
frequent
found
pathogen
two
cohort
rhinoenteroviru
hrhv
influenza
b
infb
magpix
instrument
provid
dr
j
daam
luminex
austin
texa
